Literature DB >> 16319405

Measuring outcome priorities and preferences in people with schizophrenia.

Robert Rosenheck1, Scott Stroup, Richard S E Keefe, Joseph McEvoy, Marvin Swartz, Diana Perkins, John Hsiao, Martha Shumway, Jeffrey Lieberman.   

Abstract

BACKGROUND: Measures have not taken account of the relative importance patients place on various outcomes. AIMS: To construct and evaluate a multidimensional, preference-weighted mental health index.
METHOD: Each of over 1200 patients identified the relative importance of improvement in six domains: social life, energy, work, symptoms, confusion and side-effects. A mental health index was created in which measures of well-being in these six domains were weighted for their personal importance.
RESULTS: The strongest preference was placed on reducing confusion and the least on reducing side-effects. There was no significant difference between the unweighted and preference-weighted mental health status measures and they had similar correlations with global health status measures. Patients with greater preference for functional activities such as work had less preference for medical model goals such as reducing symptoms and had less symptoms.
CONCLUSIONS: A preference-weighted mental health index demonstrated no advantage over an unweighted index.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319405     DOI: 10.1192/bjp.187.6.529

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  22 in total

Review 1.  A descriptive review on methods to prioritize outcomes in a health care context.

Authors:  Inger M Janssen; Ansgar Gerhardus; Milly A Schröer-Günther; Fülöp Scheibler
Journal:  Health Expect       Date:  2014-08-25       Impact factor: 3.377

2.  Constructing evidence-based treatment strategies using methods from computer science.

Authors:  Joelle Pineau; Marc G Bellemare; A John Rush; Adrian Ghizaru; Susan A Murphy
Journal:  Drug Alcohol Depend       Date:  2007-02-21       Impact factor: 4.492

3.  Physical wellness and employment status among adults with serious mental illness.

Authors:  Richard W Goldberg; Ann Hackman; Deborah R Medoff; Clayton Brown; Li Juan Fang; Faith Dickerson; Julie Kreyenbuhl; Lisa Dixon
Journal:  Community Ment Health J       Date:  2008-03-18

4.  Extrapyramidal side-effects of antipsychotics in a randomised trial.

Authors:  Del D Miller; Stanley N Caroff; Sonia M Davis; Robert A Rosenheck; Joseph P McEvoy; Bruce L Saltz; Silvana Riggio; Miranda H Chakos; Marvin S Swartz; Richard S E Keefe; T Scott Stroup; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2008-10       Impact factor: 9.319

5.  A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia.

Authors:  John F P Bridges; Lara Slawik; Annette Schmeding; Jens Reimer; Dieter Naber; Olaf Kuhnigk
Journal:  Health Expect       Date:  2011-06-14       Impact factor: 3.377

Review 6.  Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical review.

Authors:  Takefumi Suzuki
Journal:  Psychopharmacol Bull       Date:  2011

7.  Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis.

Authors:  Steffen Moritz; Jerome Favrod; Christina Andreou; Anthony P Morrison; Francesca Bohn; Ruth Veckenstedt; Peter Tonn; Anne Karow
Journal:  Schizophr Bull       Date:  2012-02-15       Impact factor: 9.306

8.  The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis.

Authors:  Steffen Moritz; Fabrice Berna; Susanne Jaeger; Stefan Westermann; Matthias Nagel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-05-18       Impact factor: 5.270

9.  Association of participant preferences on work and school participation after a first episode of psychosis.

Authors:  Alexandra de Waal; Lisa B Dixon; Jennifer L Humensky
Journal:  Early Interv Psychiatry       Date:  2017-10-20       Impact factor: 2.732

Review 10.  The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.